MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.36M | -12.47M | -12.49M | -12.36M | -11.27M |
| Total Depreciation and Amortization | 154.50K | 167.20K | 181.90K | 197.20K | 216.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.91M | 2.95M | 3.10M | 3.78M | 1.75M |
| Change in Net Operating Assets | 2.46M | 3.04M | 3.29M | 2.80M | 1.68M |
| Cash from Operations | -6.83M | -6.32M | -5.93M | -5.58M | -7.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -5.00M | -5.00M | -- | -- | -- |
| Issuance of Common Stock | 19.41M | 18.05M | 14.90M | 13.55M | 7.90K |
| Repurchase of Common Stock | -425.20K | -425.20K | -173.40K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.99M | 12.62M | 14.72M | 13.55M | 7.90K |
| Foreign Exchange rate Adjustments | -30.40K | -12.70K | -13.30K | -14.60K | -6.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.13M | 6.29M | 8.78M | 7.95M | -7.63M |